NCAC I EXAM PREP TEST BANK 2026
COMPLETE QUESTIONS AND VERIFIED
SOLUTIONS
⩥ Schedule I. Answer: It drugs that "may lead to severe psychological or
physical dependence" HIGH ABUSE POTENTIAL and NO
ACCEPTED MEDICAL USES & CANNOT BE DISPENSED by an
authorized prescriber eg. heroin, most psychedelics, LSD
⩥ Schedule II. Answer: Schedule II-drugs that "may lead to severe
psychological or physical dependence" HIGH ABUSE POTENTIAL and
SOME ACCEPTED MEDICAL USES with severe restrictions and can
be dispensed by prescription from an authorized prescriber eg. opiates,
meth/amphetamines, & cocaine
⩥ Schedule III. Answer: dependence" MODERATE "may lead to
moderate or low physical dependence high psychological ABUSE
POTENTIAL and HAS ACCEPTED be dispensed by prescription from
authorized prescriber eg medical marijuana, MEDICAL USES can quick
barbs, steroids, & ketamine
⩥ Schedule IV. Answer: "may lead to limited physical and/or
psychological dependence" LOW ABUSE POTENTIAL and HAS
ACCEPTED MEDICAL USES can be dispensed by prescription from
authorized prescriber eg. benzos, tramadol, and soma
, ⩥ Schedule V. Answer: "may lead to limited physical and/or
psychological dependence" VERY LOW ABUSE POTENTIAL and
HAS ACCEPTED MEDICAL USES and can be dispensed by
prescription from an authorized prescriber cough suppressants with a
little codeine
⩥ tegmental area a (VTA). Answer: an area that is rich in neurons
containing the neurotransmitter dopamine. The cell bodies neurons send
projections regions of the brain involved in emotions, thoughts,
memories, and planning and cuting behaviours.
⩥ nucleus accumbens. Answer: thoughts, is a very important brain area
involved in motivation and learning, and signalling the motivational
value of stimuli
⩥ incentive sensitization,. Answer: whereby psychoactive substances
and the stimuli associated with their use take on increasing motivational
and behavioural significance.
⩥ Cognitive behavioural therapies. Answer: (A) altering the cognitive
processes that lead to maladaptive behaviours
(b) intervening in the behavioural chain of events that lead to use
(c) helping patients deal successfully with cravings
COMPLETE QUESTIONS AND VERIFIED
SOLUTIONS
⩥ Schedule I. Answer: It drugs that "may lead to severe psychological or
physical dependence" HIGH ABUSE POTENTIAL and NO
ACCEPTED MEDICAL USES & CANNOT BE DISPENSED by an
authorized prescriber eg. heroin, most psychedelics, LSD
⩥ Schedule II. Answer: Schedule II-drugs that "may lead to severe
psychological or physical dependence" HIGH ABUSE POTENTIAL and
SOME ACCEPTED MEDICAL USES with severe restrictions and can
be dispensed by prescription from an authorized prescriber eg. opiates,
meth/amphetamines, & cocaine
⩥ Schedule III. Answer: dependence" MODERATE "may lead to
moderate or low physical dependence high psychological ABUSE
POTENTIAL and HAS ACCEPTED be dispensed by prescription from
authorized prescriber eg medical marijuana, MEDICAL USES can quick
barbs, steroids, & ketamine
⩥ Schedule IV. Answer: "may lead to limited physical and/or
psychological dependence" LOW ABUSE POTENTIAL and HAS
ACCEPTED MEDICAL USES can be dispensed by prescription from
authorized prescriber eg. benzos, tramadol, and soma
, ⩥ Schedule V. Answer: "may lead to limited physical and/or
psychological dependence" VERY LOW ABUSE POTENTIAL and
HAS ACCEPTED MEDICAL USES and can be dispensed by
prescription from an authorized prescriber cough suppressants with a
little codeine
⩥ tegmental area a (VTA). Answer: an area that is rich in neurons
containing the neurotransmitter dopamine. The cell bodies neurons send
projections regions of the brain involved in emotions, thoughts,
memories, and planning and cuting behaviours.
⩥ nucleus accumbens. Answer: thoughts, is a very important brain area
involved in motivation and learning, and signalling the motivational
value of stimuli
⩥ incentive sensitization,. Answer: whereby psychoactive substances
and the stimuli associated with their use take on increasing motivational
and behavioural significance.
⩥ Cognitive behavioural therapies. Answer: (A) altering the cognitive
processes that lead to maladaptive behaviours
(b) intervening in the behavioural chain of events that lead to use
(c) helping patients deal successfully with cravings
